Navigation Links
Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital
Date:1/3/2011

esearch and development organization that strives to transform cancer to a preventable, chronic or curable disease by delivering extraordinary and accessible diagnostic and therapeutic solutions that prolong and improve patients' lives. 

Building on its successful development and evolution of CTC technology, as well as contributions to the body of science in the CTC field, Massachusetts General Hospital aims to revolutionize how oncologists detect, monitor and potentially treat cancers.

About Circulating Tumor Cells

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream.  The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

About Veridex, LLC

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value diagnostic oncology products.  Veridex's IVD products may significantly benefit patients by helping physicians make more informed decisions that enable better patient care.  Veridex's Clinical Research Solutions provide tools and services that may be used for the selection, identification and enumeration of targeted rare cells in peripheral blood for the identification of biomarkers, aiding scientists in their search for new, targeted therapies.  For more information, visit www.veridex.com

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of
'/>"/>

SOURCE Veridex, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lotus Pharmaceuticals Announces Approval of Reverse Stock Split
2. Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials
3. Stereotaxis Announces Global Initial Training Site at University of Chicago
4. Heska Corporation Announces Stockholder Approval of Reverse Split
5. Transgenomic Announces Closing of the Acquisition of Clinical Datas Diagnostic Business and the Closing of a $6 Million Financing
6. MeridianRx Announces New Client
7. Globus Medical Announces 2,000th Patient Treated with TRANSITION® Stabilization System
8. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
9. Savient Pharmaceuticals Announces Search for CEO
10. Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma
11. K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 Tissue ... the regenerative medical devices company, announces that it ... wound care market as Tissue Regenix Wound Care ... Medicare administrator, First Coast Service Options Inc. ("First ... , Puerto Rico and ...
(Date:7/29/2015)... , July 30, ... Guidance   ... including Core Earnings and ... Highlights of Q1 results  ... Underlying core earnings and underlying core EPS were flat, year-to-year , ...
(Date:7/29/2015)... -- Insulet Corporation (NASDAQ: PODD ), the leader ... Insulin Management System, today announced preliminary revenue results ... Company also announced that it will postpone the full ... call from Thursday, July 30, as originally scheduled.   ... , Preliminary second quarter revenue results: ...
Breaking Medicine Technology:Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5
... LONDON, March 19, 2007-AstraZeneca today announced that ... results from the ARISE (Aggressive Reduction of ... which studied,AGI-1067, an investigational anti-atherosclerotic agent with,antioxidant ... disease (CAD). ,The ARISE trial did not ...
... /PRNewswire-FirstCall/ --,Nuvelo, Inc. today announced that clinical data ... MACE)/TIMI 32 Phase,2 trial looking at recombinant nematode ... coronary syndromes,(NSTE-ACS) will be presented in a V-poster ... Session taking place in New,Orleans, LA, March 24-27, ...
Cached Medicine Technology:Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet,Primary Endpoint 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 3
(Date:7/30/2015)... ... July 30, 2015 , ... Well-known San Diego ... largest, family-owned low cost service and repair companies. For 35 years, they have ... growing their company to meet the demands of the changing technological environment. ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... “Beachside Nursing Center,” to announce its position as one of Medicare’s top-rated ... and staff members support the CMS rating system, which monitors health inspections, ...
(Date:7/30/2015)... ... 30, 2015 , ... Ross A. Clevens, MD, FACS has been ... of Plastic Surgery. This is Dr. Clevens’ second appointment by the prestigious school. ... developing a strong presence and a valuable mentoring program for medical students. ...
(Date:7/30/2015)... ... 30, 2015 , ... Using the latest online digital technologies, happiness expert Kay ... to prevent and manage major depression. , “Suicide is 100% preventable. The problem is ... the cracks and die needlessly everyday,” says Walker. “I’m out to end suicide. Some ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 HIV infection rates ... Florida on June 17th. Those untreated heroin use disorders share their needles and ... of dirty needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered to ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Beachside Nursing Center Releases New Video 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3
... the skin unleashes a complex cascade of chemistry to stem ... of Medicine in St. Louis have used evolutionary clues to ... new light on common bleeding disorders. The long tube-shaped ... von Willebrand Factor (VWF). Made in cells that form the ...
... to improve global health, alleviate hunger, raise living standards ... an important role to play. Jagdev ... and Vaccinology at Arizona State University,s Biodesign Institute has ... of chicken for villagers in rural Uganda. He reports ...
... WEDNESDAY, July 20 (HealthDay News) -- The number of surgical ... new study finds. In reviewing adverse events and close ... report in the July 15 issue of the Archives ... a greater emphasis on safety, as well as improved training ...
... in the Breast Health Center at Women & Infants ... to earn a 2011 Breast Cancer Symposium Merit Award ... of Clinical Oncology (ASCO). The award, which recognizes ... to Shannon MacLaughlan, MD, who is also affiliated with ...
... that is affected during the onset of schizophrenia and successfully ... drug currently in advanced clinical trials., The research, published ... group led by Professor Peter Giese at King,s College London, ... Schizophrenia is one of the most common serious mental health ...
... of thousands of people, injuring a muscle through an accident ... in a strange and serious complication. Their muscles start growing ... abnormal bone growth, so there was no treatment. But now, ... Perelman School of Medicine at the University of Pennsylvania shows ...
Cached Medicine News:Health News:Evolution provides clue to blood clotting 2Health News:Evolution provides clue to blood clotting 3Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 2Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 3Health News:Fewer Surgical Errors Reported at VA Medical Facilities 2Health News:Cancer drugs may help treatment of schizophrenia 2Health News:When injured muscles mistakenly grow bones 2
... new Oculus Easygraph is a corneal ... tools you need for refractive surgery, ... therapy contact lens fitting in a ... 4" package. All you need to ...
The only ergonomic work station of its kind with an optional built-in keratograph and flat-screen. The Concepta is a modern workstation for the examination and refraction of patients....
The natural look of 3 in 1 technology in virtually any prescription....
Dot matrix pattern for light eyed patients....
Medicine Products: